Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias

European Journal of Immunology

Volumn 29, Issue 8, 1999, Pages 2567-2578

  Charbonnier, Aude ^a   Gaugler, Béatrice ^b   Sainty, Danielle ^b   Lafage Pochitaloff, Marina ^b   Olive, Daniel ^a,b  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Acute myeloid leukemia; Cytotoxic T lymphocyte; Dendritic cell

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; INTERLEUKIN 12;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KARYOTYPE; LEUKEMIA CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

ADOLESCENT; ADULT; AGED; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, NEOPLASM; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELL DIFFERENTIATION; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; HUMANS; IMMUNIZATION; IMMUNOGLOBULINS; INTERLEUKIN-12; ISOANTIGENS; LEUKEMIA, MONOCYTIC, ACUTE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PHENOTYPE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032810007     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199908)29:08<2567::AID-IMMU2567>3.0.CO;2-S     Document Type: Article

References (38)

1. Goulmy, E., Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol. Rev. 1997. 157: 125-140.
2. Boon, T. and van der Bruggen, P., Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 1996. 183: 725-729.
3. Bocchia, M., Wentworth, P. A., Southwood, S., Sidney, J., McGraw, K., Scheinberg, D. A. and Sette, A., Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules. Blood 1995. 85: 2680-2684.
4. Bocchia, M., Korontsvit, T., Xu, Q., Mackinnon, S., Yang, S. Y., Sette, A. and Scheinberg, D. A., Specific human cellular immunity to brc-abl oncogene-derived peptides. Blood 1996. 87: 3587-3592.
5. Yotnda, P., Firat, H., Garcia-Pons, F., Gourru, G., Vernant, J. P., Lemonier, F. A., Leblond, V. and Langlade-Demoyen, P., Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia. J. Clin. Invest. 1997. 101: 2290-2296.
6. Cella, M., Sallusto, F. and Lanzavecchia, A., Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 1997. 9: 10-16.
7. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
8. Huang, A., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D. and Levitsky, H., Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994. 264: 961-965.
9. Mayordomo, J., Zorina, T., Storkus, W., Zitvogel, L., Celluzzi, C., Falo, L., Melief, C., Ildstad, S., Martin Kast, W., Deleo, A. and Lotze, M., Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med. 1995. 1: 1297-1302.
10. Gabrilovich, D., Chen, H., Girgis, K., Cunningham, H., Meny, G., Nadaf, S., Kavanaugh, D. and Carbone, D., Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Med. 1996. 2: 1096-1103.
11. Koch, F., Stanzl, U., Jennewein, P., Janke, K., Heufler, C., Kämpgen, E., Romani, N. and Schuler, G., High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and down-regulation by IL-4 and IL-10. J. Exp. Med. 1996. 184: 741-746.
12. Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P. and Linsley, P. S., Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992. 71: 1093-1102.
13. Gong, J., Chen, D., Kashiwaba, M. and Kufe, D., Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nature Med. 1997. 3: 558-561.
14. Lespagnard, L., Mettens, P., Verheyden, A., Tasiaux, N., Thielemans, K., van Meirvenne, S., Geldhof, A., De Baetselier, P., Urbain, J., Leo, O. and Moser, M., Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity. Int. J. Cancer 1998. 76: 250-258.
15. Cardoso, A., Seamon, M., Afonso, H., Ghia, P., Boussiotis, V., Freeman, G., Gribben, J., Sallan, S. and Nadler, L., Ex vivo generation of human anti-pre B leukemia-specific autologous cytolytic T cells. Blood 1997. 90: 549-561.
16. Choudhury, A., Gajewski, J., Liang, J., Popat, U., Claxton, D., Kliche, K., Andreeff, M. and Champlin, R., Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 1997. 89: 1133-1142.
17. Choudhury, A., Toubert, A., Sutaria, S., Charron, D., Champlin, R. and Claxton, D., Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicity. Crit. Rev. Immunol. 1998. 18: 121-131.
18. Choudhury, A., Liang, J. C., Thomas, E. K., Flores-Romo, L., Xie, Q. S., Agusala, K., Sutaria, S., Sinha, I., Champlin, R. E. and Claxton, D. F., Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T cell responses. Blood 1999. 93: 780-786.
19. Costello, R. T., Mallet, F., Sainty, D., Maraninchi, D., Gastaut, J. A. and Olive, D., Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition. Eur. J. Immunol. 1998. 28: 90-103.
20. Zhou, L. and Tedder, T., Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 1995. 154: 3821-3835.
21. Armstrong, T., Pulaski, B. and Ostrand-Rosenberg, S., Tumor antigen presentation: changing the rules. Cancer Immunol. Immunother. 1998. 46: 70-74.
22. Zitvogel, L., Mayordomo, J., Tjandrawan, T., DeLeo, A., Clarke, M., Lotze, M. and Storkus, W., Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 1996. 183: 87-97.
23. Smit, W., Rijnbeek, M., van Bergen, C., de Paus, R., Vervenne, H., van de Keur, M., Willemze, R. and Falkenburg, J., Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells. Hum. Immunol. 1997. 53: 216-223.
24. Eibl, B., Ebner, S., Duba, C., Bock, G., Romani, N., Erdel, M., Gachter, A., Niederwieder, D. and Schuler, G., Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response. Genes Chromosom. Cancer 1997. 20: 215-223.
25. Coleman, S., Throp, D., Fisher, J., Bailey-Wood, R. and Lim, S., Cytokine enhancement of immunogenicity in chronic myeloid leukemia. Leukemia 1998. 11: 2055-2059.
26. Misery, L., Campos, L., Dezutter-Dambuyant, C., Guyotat, D., Treille, D., Schmitt, D. and Thivolet, J., CD1-reactive leukemic cells in bone marrow: presence of Langerhans cell marker on leukemic monocytic cells. Eur. J. Haematol. 1992. 48: 27-32.
27. Santiago-Schwarz, F., Coppock, D., Hindenburg, A. and Kern, J., Identification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemia. Blood 1994. 84: 3054-3062.
28. Srivastava, B., Srivastava, A. and Srivastava, M., Phenotype, genotype and cytokine production in acute leukemia involving progenitors of dendritic Langerhans' cells. Leuk Res 1994. 18: 499-511.
29. Gruss, H., Herrmann, F., Gattei, V., Gloghini, A., Pinto, A. and Carbone, A., CD40/CD40 ligand interactions in normal, reactive and malignant lympho-hematopoietic tissues. Leuk. Lymphoma 1997. 24: 393-422.
30. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., van Kooten, C., Durand, I. and Banchereau, J., Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 1994. 180: 1263-1272.
31. McLellan, A., Sorg, R., Williams, L. and Hart, D., Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway. Eur. J. Immunol. 1996. 26: 1204-1210.
32. + T cell help. J. Exp. Med. 1997. 186: 65-70.
33. Bennett, S., Carbone, F., Karamalis, F., Flavell, R., Miller, J. and Heath, W., Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998. 393: 478-480.
34. + T-helper and a T-killer cell. Nature 1998. 393: 474-478.
35. Schoenberger, S., Toes, R., van der Voort, E., Offringa, R. and Melief, C., T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998. 393: 480-483.
36. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994. 179: 1109-1118.
37. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A. and Alber, G., Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 1996. 184: 747-752.
38. Renard, N., Lafage-Pochitalof, M., Durand, I., Duvert, V., Goignet, L., Banchereau, J. and Saeland, S., Demonstration of functional CD40 in B-lineage acute lymphoblastic leukemia cells in response to T-cell CD40 ligand. Blood 1996. 87: 5162-5170.